Serological evidence of human granulocytic ehrlichiosis in Switzerland.
To investigate whether human granulocytic ehrlichiosis (HGE) is prevalent in Switzerland, 1515 human serum samples from individuals with different risks for tick exposure were tested for antibodies to Ehrlichia phagocytophila, a surrogate marker of the agent of HGE. The distribution of titres showed marked differences between sera of individuals with no or low risk for tick exposure and those with a high risk. The results of serological testing provided evidence of HGE in Switzerland as well as evidence of two types of coinfections: those with the agent of HGE and Borrelia burgdorferi, and those with the agent of HGE and the central European tickborne encephalitis virus.
Pusterla
N
N
Department of Veterinary Internal Medicine, University of Zurich, Switzerland.
Weber
R
R
Wolfensberger
C
C
Schär
G
G
Zbinden
R
R
Fierz
W
W
Madigan
J E
JE
Dumler
J S
JS
Lutz
H
H
D000907:Antibodies, Bacterial / Q000097:blood; D004536:Ehrlichia; D016873:Ehrlichiosis / Q000453:epidemiology*; D006098:Granulocytes / Q000382:microbiology; D006801:Humans; D007231:Infant, Newborn; D015995:Prevalence; D013557:Switzerland / Q000453:epidemiology
D000907:Antibodies, Bacterial